MedPath

Predictors of Pulmonary Hypertension in Patients With Hypersensitivity Pneumonitis

Not Applicable
Completed
Conditions
Pulmonary Hypertension
Hypersensitivity Pneumonitis
Interventions
Procedure: Right heart catheter
Registration Number
NCT05458635
Lead Sponsor
Cairo University
Brief Summary

Hypersensitivity pneumonitis (HP) is a complex immune mediated disorders caused by repeated inhalation of and sensitization to wide range of antigens including organic particles and chemical compounds, leading to exaggerated immuneresponse. Hypersenstivity pneumonitis is a common form of diffuse parenchymal lung diseases in Egypt .Pulmonary hypertension has been found as a complication of a number of diseases affecting the lung interstitium, including hypersensitivity pneumonitis, with subsequent affection of the life expectancy Rationale of the study: to find predictors for the development of pulmonary hypertension in patients with hypersensitivity pneumonitis

Detailed Description

Cross sectional study included 60 patients with established diagnosis of HP , work up includes history of exposure, clinical examination, HRCT chest, ABGs,6MWD, desaturation degree , spirometry, echocardiography and right heart catheter in patients with high echo probability of PH.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • All patients with confirmed diagnosis of Hypersensitivity pneumonitis
Exclusion Criteria
  • Other interstitial lung diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HP with Pulmonary hypertionRight heart catheterHRCT chest , pulmonary functions ,echocardiography and RT heart catheter in high echocardiographic probability of PH
Primary Outcome Measures
NameTimeMethod
Percentage of pulmonary hypertension in patients with HP6 months

primary oucome

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kasr alainy school of medicine

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath